References
- Köhler M, Greil C, Hudecek M, et al. Current developments in immunotherapy in the treatment of multiple myeloma. Cancer. 2018;124(10):2075–2085.
- Koshiaris C, Oke J, Abel L, et al. Van den Bruel A. Quantifying intervals to diagnosis in myeloma: a systematic review and meta-analysis. BMJ Open. 2018;8(6):e019758.
- Panaroni C, Yee AJ, Raje NS. Myeloma and bone disease. Curr Osteoporos Rep. 2017;15(5):483–498.
- Larocca A, Dold SM, Zweegman S, et al. Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN). Leukemia. 2018;32(8):1697–1712.
- Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364(11):1046–1060.
- Gay F, Engelhardt M, Terpos E, et al. From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives. Haematologica. 2018;103(2):197–211.
- Graziani G, Herget GW, Ihorst G, et al. Time from first symptom onset to the final diagnosis of Multiple Myeloma (MM) - possible risks and future solutions: retrospective and prospective ‘Deutsche Studiengruppe MM’ (DSMM) and ‘European Myeloma Network’ (EMN) analysis. Leuk Lymphoma. 2020;61(4):875–886.
- Deyo RA, Weinstein JN. Low back pain. N Engl J Med. 2001;344(5):363–370.
- Deyo RA, Rainville J, Kent DL. What can the history and physical examination tell us about low back pain? JAMA. 1992;268(6):760–765.
- Koes BW, van Tulder MW, Thomas S. Diagnosis and treatment of low back pain. BMJ. 2006;332(7555):1430–1434.
- Meals RA, Hungerford DS, Stevens MB. Malignant disease mimicking arthritis of the hip. JAMA. 1978;239(11):1070–1071.
- DeAngelis NA, Busconi BD. Assessment and differential diagnosis of the painful hip. Clin Orthop Relat Res. 2003;406:11–18.
- Manchikanti L, Singh V, Datta S, et al. American society of interventional pain physicians. Comprehensive review of epidemiology, scope, and impact of spinal pain. Pain Physician. 2009;12(4):E35–E70.
- Pawlyn C, Jackson GH. Physicians, paraproteins and progress: diagnosis and management of myeloma. Br J Hosp Med (Lond). 2019;80(2):91–98.
- Engelhardt M, Shoumariyeh K, Rösner A, et al. Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany. Haematologica. 2020. DOI:10.3324/haematol.2020.262758
- Henschke N, Maher CG, Ostelo RWJG, et al. Red flags to screen for malignancy in patients with low-back pain. Cochrane Database Syst Rev 2013;CD008686. DOI:10.1002/14651858.CD008686.pub2
- Casser HR, Seddigh S, Rauschmann M. Acute lumbar back pain. Dtsch Arztebl Int. 2016;113(13):223–234.
- Chenot JF, Greitemann B, Kladny B, et al. Clinical practice guideline: non-specific low back pain. Dtsch Arztebl Int. 2017;114(51–52):883–890.
- Oliveira CB, Maher CG, Pinto RZ, et al. Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview. Eur Spine J. 2018;27(11):2791–2803.
- Kariyawasan CC, Hughes DA, Jayatillake MM, et al. Multiple myeloma: causes and consequences of delay in diagnosis. Qjm. 2007;100(10):635–640.
- Zamagni E, Cavo M, Fakhri B, et al. Bones in multiple myeloma: imaging and therapy. Am Soc Clin Oncol Educ Book. 2018;38:638–646.
- Zamagni E, Tacchetti P, Cavo M. Imaging in multiple myeloma: How? When? Blood. 2019;133(7):644–651.
- Thorsteinsdottir S, Gislason G, Aspelund T, et al. Fractures and survival in multiple myeloma: results from a population-based study. Haematologica. 2020;105(4):1067–1073.
- Herget GW, Wäsch R, Klein L, et al. Prevention of bone disease and early detection of impending fractures in multiple myeloma patients can reduce morbidity and mortality: the necessity of interdisciplinary state-of-the-art treatment. Haematologica. 2020;105(4):859–861.
- Friese CR, Abel GA, Magazu LS, et al. Diagnostic delay and complications for older adults with multiple myeloma. Leuk Lymphoma. 2009;50(3):392–400.
- Raje N, Terpos E, Willenbacher W, et al. Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study. Lancet Oncol. 2018;19(3):370–381.
- Yusuf M, Finucane L, Selfe J. Red flags for the early detection of spinal infection in back pain patients. BMC Musculoskelet Disord. 2019;20(1):606.
- Goldschmidt N, Zamir L, Poperno A, et al. Presenting signs of multiple myeloma and the effect of diagnostic delay on the prognosis. J Am Board Fam Med. 2016;29(6):702–709.
- Polanco-Armenta AG, Elizaldes-Martínez E, Torres-Gonzalez R, et al. Epidemiological panorama of orthopedic spine pathology in Mexico. Coluna/Columna. 2018;17(2):120–123.
- Miseer S, Mann T, Davis JH. Burden and profile of spinal pathology at a major tertiary hospital in the Western Cape, South Africa. SA Orthop J. 2019;18(1):33–39.
- Donner-Banzhoff N, Roth T, Sönnichsen AC, et al. Evaluating the accuracy of a simple heuristic to identify serious causes of low back pain. Fam Pract. 2006;23(6):682–686.